v3.25.4
Loss per Share (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share, Including Antidilutive Securities Excluded from Computation of Earnings Per Share
Basic and diluted loss per share for the years ended December 31, 2025, 2024 and 2023, respectively consisted of the following (in thousands, except per share data):
Years Ended December 31,
202520242023
Numerator (Basic and Diluted):
Net loss$(1,909)$(12,362)$(34,035)
Change in value for stock settled consideration(1)
(4)3165
Adjusted net loss$(1,913)$(12,331)$(33,970)
Denominator:
Basic
Weighted average common shares issued and outstanding38,96038,69538,674
Deduct: Unvested RSAs (2)
(17)(17)(15)
Weighted average common shares outstanding38,94338,67838,659
Basic loss per common share$(0.05)$(0.32)$(0.88)
Diluted
Weighted average common shares outstanding from above38,94338,67838,659
Add: Dilutive effect of RSUs, RSAs, PSUs & ESPP(3)
———
Weighted average common shares outstanding38,94338,67838,659
Diluted loss per common share$(0.05)$(0.32)$(0.88)
Antidilutive shares excluded from diluted earnings per common share(4)
1,1009621,593
(1)Relates to contingently issuable stock settled consideration.
(2)RSAs were issued and outstanding to the non-employee directors and will vest in full on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders, subject to service requirements. See Note 11 – “Stock-Based Compensation Plans” for additional information.
(3)Shares related to the Company's RSUs, RSAs, PSUs, Amended ESPP, and contingently issuable shares were excluded from the weighted average common shares outstanding for the year ended December 31, 2025 because inclusion of such shares would be antidilutive in a period of loss.
(4)Primarily pertaining to RSU grants to the Company’s employees and independent contractors.